In a macro environment where risk assets are under pressure from inflation and rate concerns, positive health developments that boost workforce productivity and economic output are a subtle tailwind. However, the crypto market is more sensitive to liquidity and regulatory signals than to medical breakthroughs, so the effect is indirect and delayed.

Two drugs show promise in reducing the risk of long COVID based on rigorous trials.